Press release
Healthcare News: Xerostomia Therapeutics Market 2018 Comprehensive Analysis | Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc, Mission Pharmacal Company
Xerostomia Therapeutics Market
The Global Xerostomia Therapeutics Market Size is anticipated to reach over USD 822.14 million by 2026 according to a new research published by Polaris Market Research.
Xerostomia is also defined as dry mouth condition causing due to absent or reduced saliva. In general, xerostomia is not considered as a disorder, but it is a condition with symptom associated with various medical situations such as a side effect of a radioactivity to the head and neck generally during chemotherapy or a side effect of a number of medications. It may or may not be associated with decreased salivary gland function. Xerostomia is a common problem majorly observed in geriatric population affecting around 20% of the individuals. However, xerostomia does not act to be age-related disorder itself as xerostomia is generally caused as a side effect.
To Explore More | Get PDF sample report - https://www.polarismarketresearch.com/industry-analysis/global-xerostomia-therapeutics-market/request-for-free-sample
The rise in favorable reimbursement scenario for xerostomia products and growing awareness about related with ailments are the major factors contributing the global xerostomia therapeutics market growth. Moreover, growing occurrence of xerostomia and related diseases such as hypertension, Parkinson’s disease, Sjogren’s syndrome, and diabetes has an affirmative influence on the global market. According to the industry reports, approximately 25 million individuals in the U.S. experience dry mouth. Moreover, according to Sjogren Syndrome Foundation of America, approximately 4 million Americans are suffering Sjogren’s syndrome.
Rising resourcefulness for the growth of awareness regarding xerostomia another factors expected to drive the market growth. For instance, Sjogren Syndrome Foundation of America conducts wakefulness programs to support people suffering the syndrome in North America. In addition, the foundation introduced the ‘5-Year Breakthrough Goal’ in 2012 with an object to cure the xerostomia as well as decrease the time required to analyze it. Moreover, key players are focusing on acquiring developing establishments and conduct lineups to increase consciousness regarding xerostomia, further enhancing the global xerostomia therapeutics market growth significantly.
The global Xerostomia Therapeutics Market is segmented on the basis of product, distribution channel, and geography.
Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/global-xerostomia-therapeutics-market/inquire-before-buying
On the basis of product, the global xerostomia therapeutics market is segmented into Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen. On the basis of products, dentifrices segment is estimated to dominate the market. The dominance is primarily due to affordability, availability, effectiveness, higher adoption amongst the users. On the basis of the distribution channel, the global xerostomia therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. In 2017, the hospital pharmacy is anticipated to dominate the market.
The dominance of hospital pharmacy is majorly due to the availability of limited branded drugs, safety & efficacy, safety, and low pricing of products. Asia Pacific is anticipated to make a dominating growth for Xerostomia Therapeutics Market during the forecast period. growing healthcare spending, the rise in inventiveness for growing awareness, and increasing occurrence of ailments such as Parkinson’s disease, diabetes, cancer, and HIV causing dry mouth conditions and factors estimated to bolster the xerostomia therapeutics market in the Asia Pacific.
Some major key players in global Xerostomia Therapeutics Market-
Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc, Mission Pharmacal Company, OraHealth Inc., OraPharma, Inc., Parnell Pharmaceuticals, Inc., Saliwell Ltd., and Sun Pharmaceutical Industries among others.
Browse Full Research Report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/global-xerostomia-therapeutics-market/
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact us
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Healthcare News: Xerostomia Therapeutics Market 2018 Comprehensive Analysis | Eisai Inc., Colgate-Palmolive Company, Dentaid, EUSA Pharma, Forward Science, GlaxoSmithKline plc, Mission Pharmacal Company here
News-ID: 1306638 • Views: …
More Releases from Polaris Market Research & Consulting
Last Mile Delivery Market Valued US$ 297.57 Billion and Expected to Register 8.6 …
According to Polaris Market Research's latest study, "Last Mile Delivery Market by Service Type (B2C, B2B, C2C); Technology (Autonomous, Non-Autonomous); Application; Region, And Segment Forecasts, 2024 - 2032," the market for last mile delivery was valued at USD 142.21 billion in 2023. It is anticipated to grow to USD 297.57 billion by 2032 and exhibit a compound annual growth rate of 8.60% during the forecast period from 2024 to 2032.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞…
Terminal Tractor Market Valued US$ 1,245.08 Million and Expected to Register 4.6 …
Polaris Market Research has added the latest Report on the Terminal Tractor Market. The report primarily includes share, size, demand, growth factors, revenue, and analysis of global companies. The global market was valued at USD 835.67 Million in 2023 and is expected to grow to USD 1,245.08 Million by 2032 at a CAGR of 4.60% during the forecast period.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/terminal-tractor-market/request-for-sample
𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧
A terminal tractor, sometimes called…
Coronary Stent Market is expected to reach US$ 12,248.80 Million by 2032, at a C …
According to Polaris Market Research's study, the Coronary Stent Market is expected to grow at a CAGR of 4.40% over the estimated period. The industry value is expected to grow from USD 8306.55 million in 2023 to USD 12,248.80 million in 2032.
The industry's growth is being fuelled by the growing pervasiveness of coronary heart disorders globally. Also, the market for coronary stents is expanding because clinical trials are being…
Public Key Infrastructure (PKI) Market Sets New Record, Projected at USD 19657.5 …
The public key infrastructure (PKI) market size is projected to be valued at USD 3032.9 million in 2023 and is expected to rise to USD 19657.5 million by 2032. The market is expected to register a CAGR of 20.6% during the forecast period. Various factors propelling the demand for PKI include:
● The public key infrastructure (PKI) industry is expanding due to notable innovation in the business and corporate sectors, which supports…
More Releases for Xerostomia
Xerostomia (Dry Mouth) Therapeutics Market Opportunities, Business Statistics Re …
The global xerostomia therapeutics market size is expected to reach USD 822.1 million by 2026 growing at a CAGR of 3.6% during the forecast period according to a new report published by Polaris Market Research.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=31976
Some of the leading companies in this market include Colgate-Palmolive Company, EUSA Pharma, GlaxoSmithKline plc, Forward Science, Mission Pharmacal Company, Eisai Inc., Ora Health Inc., Parnell Pharmaceuticals, Inc., Ora…
Global Xerostomia (Dry Mouth) Treatment Market Segmentation and Analysis Researc …
With recorded sales worth US$ 952.7 Bn in 2021, the global xerostomia (dry mouth) treatment market is expected to experience high growth over the coming years owing to increasing consumption of prescribed medicines globally. The xerostomia treatment market is estimated to expand at a CAGR of nearly 6.1% from 2022 to 2032.
Xerostomia is commonly known as dry mouth that occurs as a result of decreased or missing saliva because of…
Xerostomia Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Xerostomia Therapeutics Market will grow with a CAGR value of 3.8 percent by 2026. Factors boosting demand growth include increasing prescription drug consumption, quick accessibility & cost-effectiveness of drugs, a rising elderly population demographic, and an uptick in the incidence of disorders such as Sjogren's syndrome, HIV, diabetes, and Alzheimer's disease, among others.
Browse 151 Market Data Tables and 111 Figures spread through…
Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027
"Xerostomia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Xerostomia epidemiology and market outlook for the 7MM.
Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Xerostomia Understanding and Treatment Algorithm
The market report provides the overview of the Xerostomia by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches…
Xerostomia Market: Global Market Capacity, Production, Revenue by Regions till 2 …
Xerostomia Market report gives a far reaching investigation of the Xerostomia the Research of disease transmission, giving the chronicled and forecasted information for the 7MM during the estimate time frame from 2016-2027. The report covers detailed overview of Xerostomia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns, it also helps to recognize the growth opportunities in the 7MM with respect to the patient population.
Get Sample PDF of Xerostomia…
Xerostomia (Dry Mouth) Treatment Market Growth to be Stimulated by 2025
Xerostomia, commonly known as dry mouth, is defined as a condition resulting in the limited production of saliva or alteration in the saliva quality to retain the mouth wet. Xerostomia is normally caused due to a variety of factors such as side-effects from medication, dehydration, surgery, mouth bleeding, smoking, and irradiation of neck and head. The xerostomia is not classified as a disease but as symptoms of variable disorders. Xerostomia…
